Skip to main content
. 2013 Jul 4;173(2):259–267. doi: 10.1111/cei.12102

Table 1a.

Patient characteristics in low-dose intravenous immunoglobulin (IVIg)-treated patients

IVIg treatment indication No. of patients Age in years, median (range) IVIg dose in g/kg, median (range)
Common variable immunodeficiency 5 41 (20–57) 0·38 (0·30–0·48)
Hypogammaglobulinaemia 6 60 (45–77) 0·39 (0·25–0·59)
Agammaglobulinaemia 1 30 0·25